Skip to content

Loteprednol Etabonate

Save $698/mo
52× cheaper

Loteprednol etabonate is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cycliti…

United States
$712
per month
India
$14
per month
You save
−98%
save $698/mo · 98% cheaper
339.2K US scripts/yr$236.8M potential annual savings$241.5M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC24H31ClO7

SMILES: CCOC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)OCCl

Compare the price
US price$712per month
India price$14per month
You save$69898% less

Based on 30 units per month. US $23.73 vs India $0.46 per unit.

Total over 1 periodSave $698$712$14
The bigger picture

Loteprednol Etabonate is filled about 339.2K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$241.5M
If sourced from India
$4.7M
Potential annual savings
$236.8M
98%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.